Type 2 Diabetes

Type 2 Diabetes
If you are a Type 2 Diabetic who is currently using oral antidiabetics and has a HbA1c between 7.0% and 10.0%, you may be eligible to participate in this clinical research study. The study is designed to improve future treatment options for diabetes patients.

Study duration is approximately 8 months and involves about 6 visits a year to our clinic.

Basic Entry Qualifications:
* Male or Female, age 18 or older
* Type 2 Diabetic (confirmed diagnosis)
* HbA1c levels between 7.05 – 10.0%. The COR medical team will help you determine this number.
Qualifying participants receive study-related examinations and investigational drug at no charge.

For more information, call (405) 272-8481 or complete the registration form.